ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced prostate cancer: early trial of RO7656594 begins
Disease control Recruiting nowThis early-phase study tests a new drug, RO7656594, in people with advanced or metastatic prostate cancer that has spread. The main goals are to check the drug's safety, find the best dose, and see if it can help control the cancer. About 210 participants who have already tried o…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
New drug combo targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage study tests two experimental drugs together in men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drugs work by targeting proteins on cancer cells and blocking male hormones that fuel tumor growth. The main goal is to f…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated May 17, 2026 11:31 UTC
-
5-Dose radiation trial aims to tame advanced prostate cancer
Disease control Recruiting nowThis study tests a shorter, high-precision radiation treatment (SBRT) given in just 5 sessions for people with advanced or high-risk prostate cancer. The goal is to see if it is safe and works well. About 70 participants will be enrolled at MD Anderson Cancer Center.
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New antibody cocktail aims to control advanced prostate cancer
Disease control Recruiting nowThis early-phase study tests two experimental drugs (JNJ-87189401 and JNJ-78278343) that help the immune system attack prostate cancer cells. About 355 adults with advanced prostate cancer will take part. The main goal is to find the safest dose and check for side effects.
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New scan spots prostate cancer that standard tests miss
Diagnosis Recruiting nowThis study tests whether a special PET scan using 18F-fluciclovine can better detect advanced prostate cancer that doesn't show up well on standard PSMA scans. About 30 people with metastatic prostate cancer that has low PSMA levels or neuroendocrine features will get the scan an…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated May 17, 2026 11:39 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThis study tests a new program called ENGAGE, delivered via telehealth, to help people with stage IV breast, prostate, lung, or colorectal cancer better manage symptoms like pain, fatigue, and distress. About 190 participants will be randomly assigned to either ENGAGE or standard…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Lab-Grown Mini-Tumors could personalize prostate cancer care
Knowledge-focused Recruiting nowThis study aims to improve how doctors choose treatments for aggressive prostate cancer. Researchers will grow 3D mini-tumors from patient samples and test different therapies on them to see which works best. The goal is to find the most effective lab technique for predicting ind…
Matched conditions: ADVANCED PROSTATE CANCER
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated May 17, 2026 11:37 UTC
-
Double scan strategy could unlock prostate cancer secrets
Knowledge-focused Recruiting nowThis study will use two different PET scans (PSMA and FDG) in 30 men with advanced prostate cancer to learn more about how the disease behaves at different stages and during treatment. The goal is to gather information that could help doctors choose better treatments and monitor …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC